Efforts to optimize drug delivery systems, such as nanoparticle-based carriers, may enhance the precision and efficacy of ferroptosis inhibitors while minimizing off-target effects
reveal that a small peptide GLP-1R agonist penetrates the brain and activates a subset of GLP-1Rexpressing neurons in the arcuate nucleus to produce weight loss
Lebers Disease: People with Lebers disease, a rare inherited eye condition, should avoid vitamin B12 injections
Role of appetite-regulating peptides in the pathophysiology of addiction: implications for pharmacotherapy
Davioud-Charvet E, Delarue S, Biot C, Schwobel B, Boehme CC, Mussigbrodt A, Maes L, Sergheraert C, Grellier P, Schirmer RH and Becker K
GLP-1 receptor agonist-associated tumor adverse events: a real-world study from 2004 to 2021 based on FAERS